D
Dean Eliott
Researcher at Massachusetts Eye and Ear Infirmary
Publications - 282
Citations - 8302
Dean Eliott is an academic researcher from Massachusetts Eye and Ear Infirmary. The author has contributed to research in topics: Vitrectomy & Retinal detachment. The author has an hindex of 38, co-authored 261 publications receiving 6897 citations. Previous affiliations of Dean Eliott include Wayne State University & Kresge Eye Institute.
Papers
More filters
Journal ArticleDOI
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
Steven D. Schwartz,Carl D. Regillo,Byron L. Lam,Dean Eliott,Philip J. Rosenfeld,Ninel Z. Gregori,Jean-Pierre Hubschman,Janet L. Davis,Gad Heilwell,Marc J. Spirn,Joseph I. Maguire,Jane Bateman,Rosaleen Ostrick,Debra Morris,Matthew Vincent,Eddy Anglade,Lucian V. Del Priore,Robert Lanza +17 more
TL;DR: The results suggest that hESC-derived cells could provide a potentially safe new source of cells for the treatment of various unmet medical disorders requiring tissue repair or replacement.
Journal ArticleDOI
Interim Results from the International Trial of Second Sight's Visual Prosthesis
Mark S. Humayun,Jessy D. Dorn,Lyndon da Cruz,Gislin Dagnelie,José-Alain Sahel,Paulo E. Stanga,Artur V. Cideciyan,Jacque L. Duncan,Dean Eliott,Eugene Filley,Allen C. Ho,Arturo Santos,Avinoam B. Safran,Aries Arditi,Lucian V. Del Priore,Lucian V. Del Priore,Robert J. Greenberg +16 more
TL;DR: The long-term safety results of Second Sight's retinal prosthesis system are acceptable, and most subjects with profound visual loss perform better on visual tasks with system than without it.
Journal ArticleDOI
Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Are Present in Epiretinal and Choroidal Neovascular Membranes
TL;DR: Colocalization of two growth factors in the same cells of ocular neovascular membranes suggests that more than one growth factor may contribute to pathologic angiogenesis and suggests that hypoxia may be an etiologic factor for choroidal as well as for retinal neov vascularization.
Journal Article
Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
TL;DR: Vascular endothelial growth factor expression precedes retinal neovascularization in the retinas and the optic nerves of humans with diabetes and its localization to glial cells of the inner retina and the anterior optic nerve suggests a relationship to neov vascularization in these sites.
Journal ArticleDOI
Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial
Lyndon da Cruz,Jessy D. Dorn,Mark S. Humayun,Gislin Dagnelie,James T. Handa,Pierre Olivier Barale,José-Alain Sahel,Paulo E. Stanga,Farhad Hafezi,Farhad Hafezi,Avinoam B. Safran,Joel Salzmann,Arturo Santos,David G. Birch,Rand Spencer,Artur V. Cideciyan,Eugene de Juan,Jacque L. Duncan,Dean Eliott,Dean Eliott,Amani A. Fawzi,Amani A. Fawzi,Lisa C. Olmos de Koo,Allen C. Ho,Gary C. Brown,Julia A. Haller,Julia A. Haller,Carl D. Regillo,Lucian V. Del Priore,Aries Arditi,Robert J. Greenberg +30 more
TL;DR: The 5-year results of theArgus II trial support the long-term safety profile and benefit of the Argus II System for patients blind as a result of RP.